Show simple item record

dc.contributor.authorBailey, Matthew
dc.contributor.authorAbraham, H
dc.contributor.authorMaddock, D
dc.contributor.authorAshford, R
dc.contributor.authorHayward, C
dc.date.accessioned2022-11-09T11:16:27Z
dc.date.available2022-11-09T11:16:27Z
dc.date.issued2022-10-04
dc.identifier.urihttp://hdl.handle.net/10026.1/19944
dc.description.abstract

Over the past decade, it has been widely accepted that a paperless approach to certain aspects of clinical trials can increase quality, efficiency and, in many cases, reduce risk. Handling large amounts of clinical trial data on paper can become very expensive, difficult to maintain, and has been linked to a higher rate of data errors and omissions. Tangible improvements can be made to studies when they are designed with modern technology in mind. For example, participant diversity and inclusion can be increased or the time and mon¬¬ey spent on the collection, management, and validation of clinical trial data reduced. Computer system validation (CSV) is the documentation and proof that a process, service, or product yields an expected result. It is an important part of the development and testing of computer systems within clinical trials and applies not only to specialist eSystem vendors, but also to Clinical Trials Units (CTUs). Can a paperless approach to CSV further improve both quality and efficiency, while also satisfying the regulatory requirement to be always ‘inspection ready’?

When designing clinical trial management and data capture systems there can be an immense resource overhead. A user requirement specification is created from a protocol, which is then developed into a computer system. However, before any computer system can be implemented for use in a clinical trial, an appropriate level of CSV is required. CSV ensures all systems meet the approved specification, adhere to the CTU’s standard operating procedures and good clinical practice (GCP), ultimately producing reliable data. We provide a case study of a randomised control trial (non-regulated) where bespoke clinical trial management software is integrated with a third-party electronic data capture solution, REDCap Cloud. We discuss the application and implementation of the procedures put in place to minimise paper sign-off on specification, testing and validation documents. We consider the ability of version control software, cloud computing environments and automated build/deployment pipelines to aid in meeting regulatory GCP guidelines.

By replacing historically paper-centric tasks in our CSV processes we have seen a visible improvement in the efficiency of system development. We have strengthened the traceability of task execution and have a higher degree of confidence in the approval steps required across a system’s development. The remaining challenge we face is to ensure regulatory inspectors have a means of accessing electronic records at inspection, either via designated user accounts or tailored reports.

dc.language.isoen
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.titleA paperless approach to clinical trial systems: from specification to validation and beyond.
dc.typepresentation
dc.identifier.doi10.5281/zenodo.7741866
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Users by role
dc.publisher.placeICTMC 2022: 6th International Clinical Trials Methodology Conference
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.5281/zenodo.7741866
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
rioxxterms.typeOther


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International

All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV